Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schuster

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2016
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful EngraftmentUsama Gergis, Emil Kuriakose, Tsiporah Shore, et al.
Frontiers in Immunology|April 23, 2020
NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4<sup>+</sup> T CellsDaniela Hainberger, Valentina Stolz, Ci Zhu, et al.
Circulation Research|June 21, 2019
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial CellsFlorian Puhm, Taras Afonyushkin, Ulrike Resch, et al.
Nature Communications|November 2, 2017
Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemiaMartin Moder, Georgia Velimezi, Michel Owusu, et al.
Leukemia|February 16, 2021
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivityJohannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, et al.
Nature Communications|August 16, 2023
Pharmacological perturbation of the phase-separating protein SMNDC1Lennart Enders, Marton Siklos, Jan Borggräfe, et al.
Nature Chemical Biology|May 10, 2016
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talkSara Sdelci, Charles-Hugues Lardeau, Cynthia Tallant, et al.
American Journal of Hematology|January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasmsJelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
Cell Reports|May 7, 2016
A Comprehensive Analysis of the Dynamic Response to Aphidicolin-Mediated Replication Stress Uncovers Targets for ATM and ATMINAbdelghani Mazouzi, Alexey Stukalov, André C Müller, et al.
Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2016
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful EngraftmentUsama Gergis, Emil Kuriakose, Tsiporah Shore, et al.
Frontiers in Immunology|April 23, 2020
NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4<sup>+</sup> T CellsDaniela Hainberger, Valentina Stolz, Ci Zhu, et al.
Circulation Research|June 21, 2019
Mitochondria Are a Subset of Extracellular Vesicles Released by Activated Monocytes and Induce Type I IFN and TNF Responses in Endothelial CellsFlorian Puhm, Taras Afonyushkin, Ulrike Resch, et al.
Nature Communications|November 2, 2017
Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemiaMartin Moder, Georgia Velimezi, Michel Owusu, et al.
Leukemia|February 16, 2021
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivityJohannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, et al.
Nature Communications|August 16, 2023
Pharmacological perturbation of the phase-separating protein SMNDC1Lennart Enders, Marton Siklos, Jan Borggräfe, et al.
Nature Chemical Biology|May 10, 2016
Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talkSara Sdelci, Charles-Hugues Lardeau, Cynthia Tallant, et al.
American Journal of Hematology|January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasmsJelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
Cell Reports|May 7, 2016
A Comprehensive Analysis of the Dynamic Response to Aphidicolin-Mediated Replication Stress Uncovers Targets for ATM and ATMINAbdelghani Mazouzi, Alexey Stukalov, André C Müller, et al.
Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Pageof 15